S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Want Diversified Exposure in the Regional Banks? Try These ETFs
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Want Diversified Exposure in the Regional Banks? Try These ETFs
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Want Diversified Exposure in the Regional Banks? Try These ETFs
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Want Diversified Exposure in the Regional Banks? Try These ETFs
NYSEARCA:FBT

First Trust NYSE Arca Biotechnology Index Fund - FBT Price, Holdings, & News

$150.78
+0.62 (+0.41%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$150.19
▼
$151.41
50-Day Range
$147.92
▼
$165.37
52-Week Range
$121.68
▼
$166.00
Volume
23,544 shs
Average Volume
37,840 shs
Market Capitalization
$1.44 billion
Assets Under Management
$1.42 billion
Dividend Yield
0.00%
Net Expense Ratio
0.55%
FBT stock logo

About First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.

Receive FBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter.

FBT ETF News Headlines

March 17, 2023 | wsj.com
NYSE Arca Securities Broker/Dealer Index
March 11, 2023 | wsj.com
NYSE Arca Gold BUGS Index
March 28, 2023 | Investor Place Media (Ad)
Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
October 22, 2022 | fool.com
First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT: FBT)
June 9, 2022 | investing.com
2 Health Care And Biotech ETFs Poised For Robust Returns This Year
June 4, 2022 | finance.yahoo.com
Best Biotech ETFs for Q3 2022
February 25, 2022 | finance.yahoo.com
Best Biotech ETFs for Q2 2022
February 20, 2022 | finance.yahoo.com
Get Ready for a Biotech ETF Comeback
March 28, 2023 | Tradewins (Ad)
Modern Day Options Trading For Beginners!
These days it takes more than willpower to succeed on Wall Street and for new traders, even small mistakes can sink an account! With "Your Guide To Successful Options Trading" by expert Wendy Kirkland, you can avoid new trader pitfalls and learn to earn in this vicious market. pixel
January 27, 2022 | seekingalpha.com
Biotech ETFs plunge in the first month of 2022, some down nearly 30%
See More Headlines
Receive FBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
First Trust
Fund Name
First Trust NYSE Arca Biotechnology Index Fund
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:FBT
Inception Date
6/19/2006
Fund Manager
Daniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE Arca Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
30

Fund Statistics

Assets Under Management
$1.42 billion
Average Daily Volume
$47,783.10
Discount/Premium
0.09%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
RBC Capital Markets

Miscellaneous

Outstanding Shares
9,550,000
Beta
0.82
Creation Unit
50,000
Creation Fee
$500.00

First Trust NYSE Arca Biotechnology Index Fund Expenses

TypeFBTHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.40%0.56%0.51%0.49%0.49%
Other Expenses0.15%0.37%0.52%0.58%0.55%
Total Expense0.55%0.71%0.68%0.71%0.68%
Fee Waiver0.00%-0.41%-0.54%-0.63%-0.58%
Net Expense0.55%0.61%0.58%0.56%0.56%

First Trust NYSE Arca Biotechnology Index Fund (FBT) Holdings & Exposure

Top 10 FBT Holdings

FBT Sector Exposure

FBT Industry Exposure

Full Holdings Details













FBT ETF - Frequently Asked Questions

How have FBT shares performed in 2023?

First Trust NYSE Arca Biotechnology Index Fund's stock was trading at $154.13 at the beginning of 2023. Since then, FBT stock has decreased by 2.2% and is now trading at $150.78.
View the best growth stocks for 2023 here.

What does FBT invest in?

First Trust NYSE Arca Biotechnology Index Fund is a equity fund issued by First Trust. FBT focuses on health care investments and follows the NYSE Arca Biotechnology Index. The fund's investments total to approximately $1.42 billion assets under management.

What stocks does First Trust NYSE Arca Biotechnology Index Fund hold?

FBT invests in 30 holdings. Some of the stocks in their portfolio include Seagen (SGEN), Sarepta Therapeutics (SRPT), FibroGen (FGEN), Illumina (ILMN), Regeneron Pharmaceuticals (REGN), Ultragenyx Pharmaceutical (RARE), ACADIA Pharmaceuticals (ACAD), Exelixis (EXEL), Exact Sciences (EXAS) and IQVIA (IQV).

What is the management fee for First Trust NYSE Arca Biotechnology Index Fund?

First Trust NYSE Arca Biotechnology Index Fund's management fee is 0.40% and has other expenses of 0.15%. The net expense ratio for FBT is 0.55%.

What other stocks do shareholders of First Trust NYSE Arca Biotechnology Index Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology Index Fund investors own include Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Walt Disney (DIS), Annaly Capital Management (NLY), ONEOK (OKE), Valero Energy (VLO), AbbVie (ABBV), Broadcom (AVGO) and Bristol-Myers Squibb (BMY).

What is First Trust NYSE Arca Biotechnology Index Fund's stock symbol?

First Trust NYSE Arca Biotechnology Index Fund trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "FBT."

Who are First Trust NYSE Arca Biotechnology Index Fund's major shareholders?

First Trust NYSE Arca Biotechnology Index Fund's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Morgan Stanley (7.80%), Wells Fargo & Company MN (5.28%), Bank of America Corp DE (5.01%), UBS Group AG (4.04%), Raymond James Financial Services Advisors Inc. (2.18%) and LPL Financial LLC (2.00%).

How do I buy shares of First Trust NYSE Arca Biotechnology Index Fund?

Shares of FBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is First Trust NYSE Arca Biotechnology Index Fund's stock price today?

One share of FBT stock can currently be purchased for approximately $150.78.

How much money does First Trust NYSE Arca Biotechnology Index Fund make?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) has a market capitalization of $1.44 billion.

This page (NYSEARCA:FBT) was last updated on 3/28/2023 by MarketBeat.com Staff